BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sieczkowska-Golub J, Jarzebicka D, Oracz G, Kierkus J. Biosimilars in paediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(35): 4021-4027 [PMID: 30254406 DOI: 10.3748/wjg.v24.i35.4021]
URL: https://www.wjgnet.com/1007-9327/full/v24/i35/4021.htm
Number Citing Articles
1
Iga Pawłowska, Leszek Pawłowski, Natalia Krzyżaniak, Ivan Kocić. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General HospitalsBioDrugs 2019; 33(2): 183 doi: 10.1007/s40259-019-00341-w
2
Stefka Stoyanova, Emanuil Yordanov, Emil Hristov, Iva Parvova, Hristo Tzachev, Valentina Petkova. Availability, affordability and drug utilization of biosimilar medicinal products, containing monoclonal antibodies in BulgariaJournal of Generic Medicines: The Business Journal for the Generic Medicines Sector 2021; : 174113432110176 doi: 10.1177/17411343211017627
3
Lin-Chau Chang. The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyondJournal of Food and Drug Analysis 2019; 27(3): 671 doi: 10.1016/j.jfda.2019.03.003